Top compounds associated with response to IGSF21


Feature Type Standardized
Nominal ANOVA
mRNA tivozanib CTRPv2 pan-cancer AAC -0.015 0.7
mRNA tosedostat CTRPv2 pan-cancer AAC 0.064 0.08
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.088 0.01
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.084 0.01
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.096 0.001
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.068 0.07
mRNA triptolide CTRPv2 pan-cancer AAC 0.03 0.4
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.14 0.005
mRNA tubastatin A GDSC1000 pan-cancer AAC 0.052 0.09
mRNA valdecoxib CTRPv2 pan-cancer AAC 0.067 0.05
Download CSV